PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.78%
Revenue growth above 1.5x 2127.T's 1.87%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
0.79%
Gross profit growth under 50% of 2127.T's 12.10%. Michael Burry would be concerned about a severe competitive disadvantage.
-4.47%
Negative EBIT growth while 2127.T is at 14.56%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.53%
Negative operating income growth while 2127.T is at 13.02%. Joel Greenblatt would press for urgent turnaround measures.
-4.66%
Negative net income growth while 2127.T stands at 14.88%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-4.66%
Negative EPS growth while 2127.T is at 14.85%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.66%
Negative diluted EPS growth while 2127.T is at 14.85%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
82.86%
10Y revenue/share CAGR under 50% of 2127.T's 219.42%. Michael Burry would suspect a lasting competitive disadvantage.
82.86%
5Y revenue/share CAGR under 50% of 2127.T's 219.42%. Michael Burry would suspect a significant competitive gap or product weakness.
63.59%
3Y revenue/share CAGR under 50% of 2127.T's 170.38%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
100.00%
10Y OCF/share CAGR in line with 2127.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
100.00%
5Y OCF/share CAGR is similar to 2127.T's 100.00%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
100.00%
3Y OCF/share CAGR similar to 2127.T's 100.00%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
201.34%
Below 50% of 2127.T's 882.30%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
201.34%
Below 50% of 2127.T's 882.30%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
123.76%
Below 50% of 2127.T's 476.13%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
126.65%
10Y equity/share CAGR above 1.5x 2127.T's 83.55%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
126.65%
5Y equity/share CAGR above 1.5x 2127.T's 83.55%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
85.78%
3Y equity/share CAGR 1.25-1.5x 2127.T's 67.62%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-42.86%
Firm’s AR is declining while 2127.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-7.86%
Inventory is declining while 2127.T stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.20%
Negative asset growth while 2127.T invests at 4.09%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.97%
50-75% of 2127.T's 5.67%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-22.28%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
1.48%
SG&A declining or stable vs. 2127.T's 8.82%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.